Terazosin Hydrochloride
- Product NDC
- 71610-594
- 11-digit product format
- 716100594
- Labeler code
- 71610
- Product ID
- 71610-594_2b26376c-c9c8-4d68-aec5-f3aa773fe7f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA074823
- Marketing category
- ANDA
- Marketing start
- 2020-06-30
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| D32S14F082 | TERAZOSIN HYDROCHLORIDE | 70024-40-7 | TERAZOSIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-594-60 | 71610059460 | 90 CAPSULE in 1 BOTTLE (71610-594-60) | 90 capsule | 2021-08-26 | No | No | Historical |
| 71610-594-80 | 71610059480 | 180 CAPSULE in 1 BOTTLE (71610-594-80) | 180 capsule | 2021-08-26 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Terazosin Capsules, USP | Aphena Pharma Solutions - Tennessee, LLC | 2021-08-26 | HUMAN PRESCRIPTION DRUG LABEL | 1 |